Laetitia Fend
Transgene (France)(FR)
Publications by Year
Research Areas
Virus-based gene therapy research, CAR-T cell therapy research, Animal Virus Infections Studies, Immunotherapy and Immune Responses, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy(2014)1,012 cited
- → Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy(2017)124 cited
- → Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death -1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition(2016)95 cited
- → Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors(2018)78 cited
- → Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts(2013)60 cited
- → TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer(2017)42 cited
- → Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer(2016)38 cited
- → Oncolytic virotherapy with an armed vaccinia virus in an orthotopic model of renal carcinoma is associated with modification of the tumor microenvironment(2015)34 cited
- → Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8+ T cell immunity to reject ‘cold’ tumors(2022)29 cited
- → By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1(2019)25 cited